Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313054911> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- W4313054911 abstract "<h3>Introduction/Background</h3> Venous thromboembolism disease (VTE) is a major cause of morbidity and mortality in patients managed for ovarian cancer. The first objective of this study is to assess the incidence of thromboembolic events and the impact of VTE occurrence in ovarian cancer patients on overall survival (OS). The secondary objective is to identify predictive factors for VTE to establish a predictive nomogram at the time of ovarian cancer diagnosis. <h3>Methodology</h3> A retrospective study from a prospective cohort of patients managed for ovarian cancer in the gynecologic oncologic surgery department of the Georges Pompidou European Hospital between January 2003 and December 2020 was performed. A survival analysis by Kaplan Meyer and Cox model and a multivariate logistic regression analysis were used. A nomogram to predict the risk of VTE at the time of ovarian cancer diagnosis was created. <h3>Results</h3> Among the 615 patients included, the incidence of VTE was 17.7%. Of 109 VTEs identified, 77 (70.9%) were observed at the time of ovarian cancer diagnosis and 49.5% of patients were asymptomatic. Patients with VTE had a significantly shorter OS compared to patients without thromboembolic events (HR = 1.62, 95% CI 1.06 – 2.49, p = 0.03). Peritoneal carcinosis index, body mass index, moderate to severe renal failure, weight loss, ASA score and histological type were associated with the occurrence of VTE at the diagnosis of ovarian cancer. VTE predictive nomogram created in this population had good internal agreement (AUC = 0.81, CI95% 0.73 – 0.89). <h3>Conclusion</h3> The incidence of VTE is high during ovarian cancer management, with many asymptomatic events. The impact of VTE is unfavorable on OS. The use of a nomogram could allow an earlier screening and thus improve the management and prognosis of patients. These results raise the question of systematic screening and its modalities in this population." @default.
- W4313054911 created "2023-01-06" @default.
- W4313054911 creator A5018095505 @default.
- W4313054911 creator A5023001652 @default.
- W4313054911 creator A5044291854 @default.
- W4313054911 creator A5059041310 @default.
- W4313054911 creator A5072157997 @default.
- W4313054911 creator A5073275625 @default.
- W4313054911 creator A5081135844 @default.
- W4313054911 date "2022-10-01" @default.
- W4313054911 modified "2023-10-18" @default.
- W4313054911 title "2022-RA-448-ESGO Venous thromboembolic disease in ovarian cancer: incidence, impact on overall survival and development of a predictive score" @default.
- W4313054911 doi "https://doi.org/10.1136/ijgc-2022-esgo.506" @default.
- W4313054911 hasPublicationYear "2022" @default.
- W4313054911 type Work @default.
- W4313054911 citedByCount "0" @default.
- W4313054911 crossrefType "proceedings-article" @default.
- W4313054911 hasAuthorship W4313054911A5018095505 @default.
- W4313054911 hasAuthorship W4313054911A5023001652 @default.
- W4313054911 hasAuthorship W4313054911A5044291854 @default.
- W4313054911 hasAuthorship W4313054911A5059041310 @default.
- W4313054911 hasAuthorship W4313054911A5072157997 @default.
- W4313054911 hasAuthorship W4313054911A5073275625 @default.
- W4313054911 hasAuthorship W4313054911A5081135844 @default.
- W4313054911 hasBestOaLocation W43130549111 @default.
- W4313054911 hasConcept C120665830 @default.
- W4313054911 hasConcept C121332964 @default.
- W4313054911 hasConcept C121608353 @default.
- W4313054911 hasConcept C126322002 @default.
- W4313054911 hasConcept C143998085 @default.
- W4313054911 hasConcept C167135981 @default.
- W4313054911 hasConcept C2780221984 @default.
- W4313054911 hasConcept C2780427987 @default.
- W4313054911 hasConcept C2908647359 @default.
- W4313054911 hasConcept C34626388 @default.
- W4313054911 hasConcept C50382708 @default.
- W4313054911 hasConcept C61511704 @default.
- W4313054911 hasConcept C71924100 @default.
- W4313054911 hasConcept C99454951 @default.
- W4313054911 hasConceptScore W4313054911C120665830 @default.
- W4313054911 hasConceptScore W4313054911C121332964 @default.
- W4313054911 hasConceptScore W4313054911C121608353 @default.
- W4313054911 hasConceptScore W4313054911C126322002 @default.
- W4313054911 hasConceptScore W4313054911C143998085 @default.
- W4313054911 hasConceptScore W4313054911C167135981 @default.
- W4313054911 hasConceptScore W4313054911C2780221984 @default.
- W4313054911 hasConceptScore W4313054911C2780427987 @default.
- W4313054911 hasConceptScore W4313054911C2908647359 @default.
- W4313054911 hasConceptScore W4313054911C34626388 @default.
- W4313054911 hasConceptScore W4313054911C50382708 @default.
- W4313054911 hasConceptScore W4313054911C61511704 @default.
- W4313054911 hasConceptScore W4313054911C71924100 @default.
- W4313054911 hasConceptScore W4313054911C99454951 @default.
- W4313054911 hasLocation W43130549111 @default.
- W4313054911 hasOpenAccess W4313054911 @default.
- W4313054911 hasPrimaryLocation W43130549111 @default.
- W4313054911 hasRelatedWork W2561149705 @default.
- W4313054911 hasRelatedWork W2920996053 @default.
- W4313054911 hasRelatedWork W3095136102 @default.
- W4313054911 hasRelatedWork W3096596520 @default.
- W4313054911 hasRelatedWork W3121026803 @default.
- W4313054911 hasRelatedWork W3131814850 @default.
- W4313054911 hasRelatedWork W3159304724 @default.
- W4313054911 hasRelatedWork W3214360919 @default.
- W4313054911 hasRelatedWork W4206088420 @default.
- W4313054911 hasRelatedWork W4242937576 @default.
- W4313054911 isParatext "false" @default.
- W4313054911 isRetracted "false" @default.
- W4313054911 workType "article" @default.